pharmaceutical

• Companies Expand Offshore Cash Hoards

  By Richard Rubin, Bloomberg  |  March 8, 2013

  Untaxed offshore holdings grew by $183 billion over last year.

• Deal to Raise Revenue on Foreign Income Gets Closer

  By Richard Rubin, Bloomberg  |  February 28, 2013

  Bipartisan deal could make it easier for U.S. companies to bring home foreign income that has been taxed elsewhere.

• First Energy Names Pearson CFO

  By Ashley Scudder  |  December 20, 2012

  New CFOs at Republic Services, Levi Strauss and Impax Laboratories; new treasurer at Loral

• Drug Co. Execs Accused in $1.5 Mln Insider Trading Ring

  By David Voreacos, Bloomberg  |  November 20, 2012

  FBI, SEC charged individuals working at Celgene, Sanofi and Stryker.

• 

  Treasurers Focus on Euro Concerns

  By Rebecca Brace  |  October 4, 2012

  European companies take steps to prepare for a possible euro break-up.

• 

  The SOX Provision that Could Blindside Your Company

  By Ashley Post, Inside Counsel  |  September 10, 2012

  A little-known section criminalizes the anticipatory obstruction of justice.

• 

  Risk Tops the Agenda in Europe

  By Rebecca Brace  |  August 6, 2012

  Treasurers keep a close eye on European banks and monitor CDS spreads to supplement credit ratings. (Jack Spitzer of Starwood Hotels)

• China Hackers Hit Businesses

  By Michael Riley and Dune Lawrence, Bloomberg  |  July 27, 2012

  ‘Comment’ group targets oil companies, patent law firms and investment banks.

• 

  Merck’s Global Banking Makeover

  By Susan Kelly  |  July 19, 2012

  Treasurer Mark McDonough, one of the finance pros on the 100 Most Influential list in 2012, describes the benefits of standardizing the pharmaceutical company’s payments.

• Financial Executives: Keeping Track

  By Shaunacy Ferro  |  June 28, 2012

  François Thibault; Peter Oleksiak; Dan Brudzynski; John Hertz; Bill Thompson; W. Scott Emerick; Michael Bauer; Shaji Procida